The organisation has its headquarters in Paris, France, with regional offices all over the world, including the West African Regional Office (BRAO) in Lomé, Togo.

Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution for injection) for the treatment of patients with macular ...

Bayer seeks EMA approval to expand aflibercept 8 mg use for macular edema post retinal vein occlusion. Phase 3 QUASAR study data showed aflibercept 8 mg improved BCVA in patients with RVO, supporting ...

Objective: This study aims to identify factors influencing successful recanalization following endovascular intervention for non-acute basilar artery occlusion (NABAO). Background: Endovascular ...

Background: Deep tiny flow voids (DTFVs) have recently been identified as a novel form of collateral circulation linked to chronic steno-occlusive atherosclerotic middle cerebral artery (MCA) lesions, ...

The following is a summary of “National Trends in Central Retinal Artery Occlusion Presentations and Stroke Workup in United States Emergency Department,” published in the March 2025 issue of American ...

What started as a tragedy, turned into advocacy work for one South Carolina woman. Cheryl Lavallee, 65, and her family have lived in Waterloo for the last nine years. The family moved to South ...